Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $357.24 | 8 | 78.1% |
| Education | $99.99 | 1 | 21.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $194.61 | 4 | $0 (2024) |
| Biogen, Inc. | $113.54 | 2 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $111.89 | 1 | $0 (2018) |
| ABBVIE INC. | $21.42 | 1 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $15.77 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $180.97 | 5 | Biogen, Inc. ($113.54) |
| 2023 | $164.37 | 3 | Mallinckrodt Hospital Products Inc. ($164.37) |
| 2018 | $111.89 | 1 | Aerie Pharmaceuticals, Inc. ($111.89) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $94.90 | General |
| Category: Ophthalmology | ||||||
| 07/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: IMMUNOLOGY | ||||||
| 06/10/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Ophthalmology | ||||||
| 05/16/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Ophthalmology | ||||||
| 05/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: EYE CARE | ||||||
| 11/02/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $34.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/06/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $111.89 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 124 | 148 | $50,168 | $10,532 |
| 2022 | 4 | 66 | 127 | $25,307 | $8,555 |
| 2021 | 5 | 131 | 228 | $49,558 | $15,919 |
| 2020 | 9 | 614 | 1,590 | $554,518 | $268,962 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $30,710 | $6,335 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 18 | $8,092 | $1,864 | 23.0% |
| 92134 | Imaging of retina | Office | 2023 | 37 | 52 | $8,266 | $1,714 | 20.7% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 29 | 31 | $3,100 | $618.45 | 20.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 24 | $8,184 | $3,275 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 21 | $5,292 | $2,038 | 38.5% |
| 92134 | Imaging of retina | Office | 2022 | 25 | 68 | $7,169 | $1,922 | 26.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 11 | 14 | $4,662 | $1,320 | 28.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 30 | 46 | $15,318 | $4,987 | 32.6% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 54 | 120 | $12,681 | $3,839 | 30.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 21 | $7,161 | $3,229 | 45.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 22 | $5,544 | $2,022 | 36.5% |
| 67028 | Injection of drug into eye | Office | 2021 | 11 | 19 | $8,854 | $1,842 | 20.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2020 | 35 | 160 | $171,840 | $116,689 | 67.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2020 | 28 | 359 | $173,253 | $97,139 | 56.1% |
| 67028 | Injection of drug into eye | Office | 2020 | 90 | 246 | $133,991 | $19,248 | 14.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 166 | 251 | $31,375 | $14,605 | 46.6% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 203 | 432 | $28,285 | $13,263 | 46.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2020 | 34 | 83 | $7,296 | $4,448 | 61.0% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 22 | 22 | $4,070 | $1,713 | 42.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 16 | 16 | $2,224 | $1,193 | 53.6% |
| 92250 | Photography of the retina | Office | 2020 | 20 | 21 | $2,184 | $663.82 | 30.4% |
About Dr. Mark Barsamian, DO
Dr. Mark Barsamian, DO is a Retina Specialist healthcare provider based in Hopedale, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821204207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Barsamian, DO has received a total of $457.23 in payments from pharmaceutical and medical device companies, with $180.97 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($357.24).
As a Medicare-enrolled provider, Barsamian has provided services to 935 Medicare beneficiaries, totaling 2,093 services with total Medicare billing of $303,968. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Retina Specialist
- Other Specialties Retina Specialist
- Location Hopedale, MA
- Active Since 05/15/2007
- Last Updated 01/29/2026
- Taxonomy Code 207WX0107X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821204207
Products in Payments
- ACTHAR (Biological) $194.61
- BYOOVIZ (Biological) $113.54
- Rhopressa (Drug) $111.89
- LUMIGAN (Drug) $21.42
- VYZULTA (Drug) $15.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.